Crossmark

Colorectal Cancer: Why Does Side Matter?

Crossref DOI link: https://doi.org/10.1007/s40265-018-0921-7

Published Online: 2018-05-22

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gallois, Claire

Pernot, Simon

Zaanan, Aziz

Taieb, Julien
License Information

Text and Data Mining valid from 2018-05-22
More Information

Article History

First Online: 22 May 2018

Compliance with Ethical Standards

:

: No funding was received for the preparation of this article.

: C. Gallois declares that she has no conflicts of interest. S. Pernot has participated in advisory boards for Amgen, has received support for travel to meetings from Amgen, Bayer, and Servier, and has a received research grant from Roche. A. Zaanan has participated in advisory boards for Merck Serono, Amgen, Roche, Sanofi, and Lilly. J. Taieb has participated in consulting and/or advisory boards for Lilly, Celgene, Shire, Servier, Merck KGaA, Sanofi, Roche Genentech, Pfizer, and Amgen.